BioHealth News
Caring Cross and ImmunoAdoptive Cell Therapy (ImmunoACT) Announce Agreement to Commercialize TriCAR-T Cell Immunotherapy for Leukemia and Lymphoma
Agreement allows ImmunoACT to develop and commercialize a novel TriCAR-T cell therapy for leukemia and lymphoma designed to decrease lapses seen in current single…
Read More
NIH Entrepreneurship Bootcamp
The NIH Entrepreneurship Bootcamp is designed to equip life science investigators and nascent companies with specialized innovation and entrepreneurship training. The course requires no…
Read More
Meet with… Johnson & Johnson’s Immunology Team on May 21st
Join us for Meet With…Johnson & Johnson’s Immunology Team at JLABS @ Washington, DC on May 21.During Digestive Disease Week 2024, our Johnson &…
Read More
Washington DC’s Nanochon closes $4M Series Seed Prime
WASHINGTON--(BUSINESS WIRE)--Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round. The round was led…
Read More
Publication Announcement: Welldoc Shares Clinical Research on AI and Weight Management
welldoc® recently presented a new clinical research paper at the 14th annual Conference on Health IT and Analytics (CHITA) in Washington, D.C. This research…
Read More
Bethesda’s AsclepiX Therapeutics Completes Enrollment in DISCOVER Trial for Neovascular Age-Related Macular Degeneration (nAMD)
BETHESDA, Md., May 06, 2024 (GLOBE NEWSWIRE) -- AsclepiX Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging computational biology from Johns Hopkins to identify and…
Read More
Rockville’s GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced topline…
Read More
BioSolution Designs Announces Formation of BeatBio Subsidiary to Develop Complex Multigenic Cardiovascular Therapies
FREDERICK, MD, UNITED STATES, May 1, 2024 /EINPresswire.com/ -- BioSolution Designs is pleased to announce the formation of its first drug development subsidiary, BeatBio,…
Read More
ARPA-H Sprinting toward solutions for women’s health
The ARPA-H Sprint for Women’s Health is a funding opportunity to address critical unmet challenges in women’s health, championing transformative innovations and tackling health conditions that…
Read More
BISNOW: Maryland Life Sciences Seeks To Shift Away From ‘A World Of Office Parks’
May 2, 2024, Emily Wishingrad, Washington, D.C. Maryland’s life sciences market, one of the largest in the country, has a lot of things going…
Read More
BioSolution Designs & RoosterBio Announce Collaboration on Genetically Modified MSCs for Biotherapeutic Development
Frederick, MD, May 2, 2024 – BioSolution Designs (BSD), a biotechnology invention studio developing proprietary platforms for multigenic gene and cell therapies, today announced…
Read More
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
Venlo, the Netherlands, April 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results for the first quarter…
Read More
MedCityNews: An Oveview of the Nation’s Largest SEED Fund
Eligible small businesses may receive millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology Transfer (STTR) programs. Funding…
Read More
Deloitte Acquires Gryphon Scientific Business to Expand Security, Science and Public Health Capabilities
Acquisition will strengthen Deloitte team with a complement of data-driven biosecurity detection, prevention and emergency response solutions ARLINGTON, Va., April 29, 2024 /PRNewswire/ -- Deloitte announced…
Read More
Pitchbook: The World’s Top Startup Cities
PitchBook’s VC Ecosystem Rankings compare global cities based on the size and maturity of their startup networks. The framework helps founders, operators and investors…
Read More